Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab + epacadostat Phase 3 trial in Japan
jRCT2080223443Phase 3Completed
- Start
- Jan 2017
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Phase 3 trial of pembrolizumab and epacadostat. Started Jan 2017; status: completed.
02
Drugs
pembrolizumabepacadostat
Beyond the preview
Go deeper on jRCT2080223443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223443.